Oria Bioscience
French tech company | Builders Republic
About
Biotech building the first industrial platform to mass-produce intact, purified cell organelles such as mitochondria and lysosomes — supplying these standardized biological building blocks to pharma companies and biotech labs for drug discovery and research.
Key facts
- Status
- Active
- Sectors
- Healthcare & Life Sciences
- Latest stage
- Seed
- Founded
- 2024
- City
- PARIS
- Region
- Auvergne-Rhône-Alpes
- Tracked rounds
- 1
- Amount raised
- 2.7 M€ raised since 2020
Funding rounds
- Seed — 2025